← Back to Clinical Trials
Recruiting NCT07491939

NCT07491939 Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07491939
Status Recruiting
Phase
Sponsor Dorothy House Hospice
Condition Inflammatory Arthritis
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2026-02-19
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
NONE - observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2026-02-19 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Palliative Care (PC) focuses on maximising quality of life and care for patients and their families in the last 1000 days of life. Supportive Care (SC) is provided earlier in life for people with a long-term health condition. People living with inflammatory arthritis, (such as rheumatoid arthritis) can experience ongoing pain, stiffness, limitations in their joints, and intrusive fatigue. This impacts daily living activities and emotional well-being. People with inflammatory arthritis would value support to manage symptoms across the course of their disease. They would like PC healthcare professionals (HCPs) to understand their conditions better, so they can live well to the end of their lives. Aims: The investigators will explore the potential role of Palliative and Supportive Care (PSC) for people with inflammatory arthritis. The investigators will describe any unmet patient need. The investigators will develop clinical and research recommendations to help people with inflammatory arthritis live well over the course of their disease. Plan: The investigators research will be conducted in three studies: Study 1: The investigators will conduct 1:1 online interviews with people with inflammatory arthritis to understand how PSC is perceived by them, and what their views are on how PSC may support them to live well. Study 2: The investigators will send an online survey to Rheumatologists, Primary Care, Community and PC HCPs, to understand: * if and how they work together currently; * their views on the role of PSC supporting people with inflammatory arthritis to live well. Study 3: The investigators will conduct online focus groups with volunteers from Studies 1 and 2, representatives from relevant national charities/organisations, and people who commission health services. Together the group will discuss the research findings and agree: * what the gap in patient care is; * recommendations for future clinical practice and research; * the key areas of importance for patients which should be measured in future work

Eligibility Criteria

Inclusion Criteria: * Adults (\> 18 years) with a diagnosis of arthritis (Rheumatoid, Psoriatic or Juvenile Idiopathic) or Axial Spondyloarthritis * able to understand and communicate in verbal and written English (or via an interpreter nominated by the participant or provided via an agency by the research team) * in receipt, or not in receipt of Palliative Care services * access to Microsoft Teams or a telephone * consent to sharing preferred contact details Exclusion Criteria: * Cognitive impairment that impedes communication * non-English speaker (should an interpreter not be available).

Contact & Investigator

Central Contact

Dr Sharon Grieve Research Development and Delivery Lead, DPhil

✉ sharon.grieve@dorothyhouse-hospice.org.uk

📞 00 44 1225 722988

Frequently Asked Questions

Who can join the NCT07491939 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07491939 currently recruiting?

Yes, NCT07491939 is actively recruiting participants. Contact the research team at sharon.grieve@dorothyhouse-hospice.org.uk for enrollment information.

Where is the NCT07491939 trial being conducted?

This trial is being conducted at Bath, United Kingdom.

Who is sponsoring the NCT07491939 clinical trial?

NCT07491939 is sponsored by Dorothy House Hospice. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology